326 related articles for article (PubMed ID: 22383146)
21. Ethical management of conflict of interest: proposed standards for academic surgical societies.
Minter RM; Angelos P; Coimbra R; Dale P; de Vera ME; Hardacre J; Hawkins W; Kirkwood K; Matthews JB; McLoughlin J; Peralta E; Schmidt M; Zhou W; Schwarze ML
J Am Coll Surg; 2011 Nov; 213(5):677-82. PubMed ID: 21880513
[TBL] [Abstract][Full Text] [Related]
22. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
Rothman DJ; McDonald WJ; Berkowitz CD; Chimonas SC; DeAngelis CD; Hale RW; Nissen SE; Osborn JE; Scully JH; Thomson GE; Wofsy D
JAMA; 2009 Apr; 301(13):1367-72. PubMed ID: 19336712
[TBL] [Abstract][Full Text] [Related]
23. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
24. Industry relationships between physicians and professional medical associations: corrupt or essential?
Smith CD; MacFadyen B
Surg Endosc; 2010 Feb; 24(2):251-3. PubMed ID: 20087748
[TBL] [Abstract][Full Text] [Related]
25. [The medical-industrial complex: an ethical challenge].
Engelhardt K
Dtsch Med Wochenschr; 2005 Jul; 130(30):1778-80. PubMed ID: 16049885
[No Abstract] [Full Text] [Related]
26. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
27. Standards for relations of cardiothoracic surgical organizations with industry.
Sade RM; ;
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):12-7. PubMed ID: 21555138
[No Abstract] [Full Text] [Related]
28. "Evidence-debased medicine" and the integrity of the medical profession.
Elliott RL
J Clin Ethics; 2011; 22(1):71-3. PubMed ID: 21595357
[TBL] [Abstract][Full Text] [Related]
29. Continuing medical education: ethical collaboration between sponsor and industry.
Wilson FS
Clin Orthop Relat Res; 2003 Jul; (412):33-7. PubMed ID: 12838049
[TBL] [Abstract][Full Text] [Related]
30. Continuing medical education and professional revalidation in Europe: five case examples.
Maisonneuve H; Matillon Y; Negri A; Pallarés L; Vigneri R; Young HL
J Contin Educ Health Prof; 2009; 29(1):58-62. PubMed ID: 19288575
[TBL] [Abstract][Full Text] [Related]
31. Medical communication companies and industry grants.
Rothman SM; Brudney KF; Adair W; Rothman DJ
JAMA; 2013 Dec; 310(23):2554-8. PubMed ID: 24346991
[TBL] [Abstract][Full Text] [Related]
32. The effect of industry support on participants' perceptions of bias in continuing medical education.
Kawczak S; Carey W; Lopez R; Jackman D
Acad Med; 2010 Jan; 85(1):80-4. PubMed ID: 20042829
[TBL] [Abstract][Full Text] [Related]
33. Managing perceived conflicts of interest while ensuring the continued innovation of medical technology.
Van Haute A
J Vasc Surg; 2011 Sep; 54(3 Suppl):31S-3S. PubMed ID: 21872113
[TBL] [Abstract][Full Text] [Related]
34. Academia-industry collaboration in continuing medical education: description of two approaches.
Katz HP; Goldfinger SE; Fletcher SW
J Contin Educ Health Prof; 2002; 22(1):43-54. PubMed ID: 12004640
[TBL] [Abstract][Full Text] [Related]
35. Continuing medical education in cardiology: the ESC perspective. European Society of Cardiology.
Oto A; Rydén L
Eur Heart J; 2000 Feb; 21(3):182-4. PubMed ID: 10639298
[No Abstract] [Full Text] [Related]
36. Physician-industry relations. Part 2: organizational issues.
Coyle SL;
Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
[TBL] [Abstract][Full Text] [Related]
37. Association of Clinical Researchers and Educators a statement on relationships between physicians and industry.
Weber MA; Black HR; Fonseca R; Garber J; Gonzalez-Campoy JM; Kimmelstiel C; Markowitz AB; Nakayama D; Stell LK; Stossel TP
Endocr Pract; 2012; 18(6):1029-37. PubMed ID: 22982801
[TBL] [Abstract][Full Text] [Related]
38. Restrictions on interactions between doctors and industry could ultimately hurt patients.
Kimmelstiel C
J Vasc Surg; 2011 Sep; 54(3 Suppl):12S-4S. PubMed ID: 21872108
[TBL] [Abstract][Full Text] [Related]
39. American Society of Clinical Oncology: Policy for relationships with companies.
American Society of Clinical Oncology
J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118
[No Abstract] [Full Text] [Related]
40. Medical education and communication companies: an updated in-depth profile.
Golden GA; Parochka JN; Overstreet KM
J Contin Educ Health Prof; 2002; 22(1):55-62. PubMed ID: 12004641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
